TITLE

Oral Session 32 (Plaza Ballroom): Therapy-Stem Cells

PUB. DATE
September 2013
SOURCE
Journal of Extracellular Vesicles;2013, Vol. 2, p137
SOURCE TYPE
Academic Journal
DOC. TYPE
Abstract
ABSTRACT
The article presents abstracts on topics related to therapy/stem cells which include biochemical potential of mesenchymal stem cell (MSC) exosomes, effectiveness of membrane TRAIL-armed exosomes as an anti-tumor therapy, and role of mesenchymal stem-cell derived exosomes on the treatment of therapy-derived acute graft-versus-host disease.
ACCESSION #
93478213

 

Related Articles

  • MSC-derived exosomes: a novel tool to treat therapy-refractory graft-versus-host disease. Kordelas, L; Rebmann, V; Ludwig, A-K; Radtke, S; Ruesing, J; Doeppner, T R; Epple, M; Horn, P A; Beelen, D W; Giebel, B // Leukemia (08876924);Apr2014, Vol. 28 Issue 4, p970 

    A letter to the editor is presented concerning a study which examines mesenchymal stem cells (MSCs)-derived exosomes as treatment for refractory graft-versus-host disease (GvHD).

  • Mesenchymal stromal cells for the treatment of graft-versus-host disease: understanding the in vivo biological effect through patient immune monitoring. Dander, E; Lucchini, G; Vinci, P; Introna, M; Masciocchi, F; Perseghin, P; Balduzzi, A; Bonanomi, S; Longoni, D; Gaipa, G; Belotti, D; Parma, M; Algarotti, A; Capelli, C; Golay, J; Rovelli, A; Rambaldi, A; Biondi, A; Biagi, E; D'Amico, G // Leukemia (08876924);Jul2012, Vol. 26 Issue 7, p1681 

    The article presents a study which examines the biological effect of mesenchymal stromal cells (MSCs) on the treatment of graft-versus-host disease (GvHD). The study was participated by 10 patients with post-transplant GvHD who were managed with multiple infusions of third-party bone...

  • Optimization of adipose tissue-derived mesenchymal stem cells by rapamycin in a murine model of acute graft-versus-host disease. Kyoung-Woon Kim; Su-Jin Moon; Min-Jung Park; Bo-Mi Kim; Eun-Kyung Kim; Sung-Hee Lee; Eun-Jung Lee; Byung-Ha Chung; Chul-Woo Yang; Mi-La Cho // Stem Cell Research & Therapy;10/23/2015, Vol. 6, p1 

    Introduction: Mesenchymal stem cells (MSCs) can protect bone marrow transplantation (BMT) recipients from the lethal acute graft-versus-host disease (aGVHD) development. However, the mechanisms underlying the anti-inflammatory properties of MSCs in aGVHD remain to be elucidated. The...

  • Allogeneic clonal mesenchymal stem cell therapy for refractory graft-versus-host disease to standard treatment: a phase I study. Hyeon Gyu Yi; Seung-Ah Yahng; Inho Kim; Je-Hwan Lee; Chang-Ki Min; Jun Hyung Kim; Chul Soo Kim; Sun U. Song // Korean Journal of Physiology & Pharmacology;2016, Vol. 20 Issue 1, p63 

    Severe graft-versus-host disease (GVHD) is an often lethal complication of allogeneic hematopoietic stem cell transplantation (HSCT). The safety of clinicalgrade mesenchymal stem cells (MSCs) has been validated, but mixed results have been obtained due to heterogeneity of the MSCs. In this phase...

  • Mesenchymal stem cells for the treatment and prevention of graft-versus-host disease: experiments and practice. Kim, Nayoun; Im, Keon-Il; Lim, Jung-Yeon; Jeon, Eun-Joo; Nam, Young-Sun; Kim, Eun-Jung; Cho, Seok-Goo // Annals of Hematology;Oct2013, Vol. 92 Issue 10, p1295 

    Mesenchymal stem cells (MSCs) have emerged as a therapeutic approach in a range of medical fields, including regenerative medicine, cancer, autoimmune diseases, and inflammatory diseases, because of their unique properties of tissue repair and major histocompatibility complex-unmatched...

  • Mesenchymal stromal cell therapy: a revolution in Regenerative Medicine? Bernardo, M E; Pagliara, D; Locatelli, F // Bone Marrow Transplantation;Feb2012, Vol. 47 Issue 2, p164 

    Because of their immunomodulatory and engraftment-promoting properties, mesenchymal stromal cells (MSCs) have been tested in the clinical setting both to facilitate haematopoietic recovery and to treat steroid-resistant acute GVHD. More recently, experimental findings and clinical trials have...

  • Mesenchymal stromal cells as treatment for chronic GVHD. Ringden, O.; Keating, A. // Bone Marrow Transplantation;Feb2011, Vol. 46 Issue 2, p163 

    The authors reflect on the use of mesenchymal stromal cells (MSCs) as treatment for acute graft versus host disease (GVHD). The authors discuss the study of J. Y. Weng and colleagues on medical outcomes of 19 patients who were treated with MSCs for refractory chronic GVHD. They mention that one...

  • Biomarker profiling of steroid-resistant acute GVHD in patients after infusion of mesenchymal stromal cells. te Boome, L C J; Mansilla, C; van der Wagen, L E; Lindemans, C A; Petersen, E J; Spierings, E; Thus, K A; Westinga, K; Plantinga, M; Bierings, M; Broers, A E C; Cuijpers, M L H; van Imhoff, G W; Janssen, J J; Huisman, C; Zeerleder, S; Huls, G; Boelens, J J; Wulffraat, N M; Slaper-Cortenbach, I C M // Leukemia (08876924);Sep2015, Vol. 29 Issue 9, p1839 

    We performed a prospective phase II study to evaluate clinical safety and outcome in 48 patients with steroid-refractory grade II-IV acute graft-versus-host disease (aGVHD) treated with mesenchymal stromal cells (MSCs). Clinical outcomes were correlated to comprehensive analyses of soluble and...

  • Advances in Adipose-Derived Stem Cells Isolation, Characterization, and Application in Regenerative Tissue Engineering. Wankhade, Umesh D.; Shen, Michael; Kolhe, Ravindra; Fulzele, Sadanand // Stem Cells International;2/11/2016, p1 

    Obesity is a complex, multifactorial disease that has been extensively researched in recent times. Obesity is characterized by excess deposition of adipose tissue in response to surplus energy. Despite the negative connotations of adipose tissue (AT), it serves as a critical endocrine organ....

Share

Read the Article

Courtesy of ASKRI - RI OFFICE OF LIBRARY AND INFORMATION SERVICES

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics